IN VIVO Dosimetry: Advantages of Using EPIGRAY® VS. DIODE
- October 9, 2016
- Category: What's New
No Comments

The recent study “Improving safety for cancer patients using a radiation dose verification system“, performed by Christchurch Hospital has demonstrated the advantages of EPIgray solutions, compared to diode.
(From “Improving safety for cancer patients using a radiation dose verification system“, Radiation Oncology Department, Canterbury Regional Cancer and Haematology Service, Christchurch Hospital, New ZealandKenta H.(2016)